BioCentury
ARTICLE | Clinical News

Aerucin regulatory update

August 3, 2015 7:00 AM UTC

FDA granted Fast Track designation to Aridis’ Aerucin to treat hospital-acquired and ventilator-associated pneumonia caused by Pseudomonas aeruginosa. The human IgG1 mAb against P. aeruginosa is in P...